- Home
- BOF vs LPCN Comparison
BOF vs LPCN Comparison
Compare BOF & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- LPCN
- Stock Information
- Founded
- BOF 2017
- LPCN 1997
- Country
- BOF United States
- LPCN United States
- Employees
- BOF N/A
- LPCN N/A
- Industry
- BOF Packaged Foods
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- LPCN Health Care
- Exchange
- BOF Nasdaq
- LPCN Nasdaq
- Market Cap
- BOF 16.7M
- LPCN 16.4M
- IPO Year
- BOF 2023
- LPCN N/A
- Fundamental
- Price
- BOF $2.41
- LPCN $3.17
- Analyst Decision
- BOF
- LPCN Strong Buy
- Analyst Count
- BOF 0
- LPCN 1
- Target Price
- BOF N/A
- LPCN $10.00
- AVG Volume (30 Days)
- BOF 185.5K
- LPCN 10.5K
- Earning Date
- BOF 05-13-2025
- LPCN 03-13-2025
- Dividend Yield
- BOF N/A
- LPCN N/A
- EPS Growth
- BOF N/A
- LPCN N/A
- EPS
- BOF N/A
- LPCN N/A
- Revenue
- BOF $6,489,951.00
- LPCN $11,198,144.00
- Revenue This Year
- BOF N/A
- LPCN N/A
- Revenue Next Year
- BOF N/A
- LPCN $37.31
- P/E Ratio
- BOF N/A
- LPCN N/A
- Revenue Growth
- BOF 372.36
- LPCN N/A
- 52 Week Low
- BOF $0.61
- LPCN $2.91
- 52 Week High
- BOF $4.11
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- BOF 57.91
- LPCN 41.52
- Support Level
- BOF $2.09
- LPCN $3.00
- Resistance Level
- BOF $2.82
- LPCN $3.57
- Average True Range (ATR)
- BOF 0.23
- LPCN 0.26
- MACD
- BOF 0.04
- LPCN -0.00
- Stochastic Oscillator
- BOF 59.80
- LPCN 23.29
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.